StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report issued on Saturday. The brokerage issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Trading Down 2.9 %
Shares of Brooklyn ImmunoTherapeutics stock opened at $1.01 on Friday. The stock’s fifty day simple moving average is $1.56 and its 200 day simple moving average is $1.87. The company has a market capitalization of $59.41 million, a PE ratio of -0.46 and a beta of 4.61. Brooklyn ImmunoTherapeutics has a 12 month low of $0.17 and a 12 month high of $10.10.
Brooklyn ImmunoTherapeutics Company Profile
See Also
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- How to Most Effectively Use the MarketBeat Earnings Screener
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- 5 Top Rated Dividend Stocks to Consider
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
